<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font24 { font-size : 24; } .font26 { font-size : 26; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">nasal </span>
   <span class="font29">[]. </span>
   <span class="font26">drug </span>
   <span class="font24">brain </span>
   <span class="font24">drugs </span>
   <span class="font21">able </span>
   <span class="font20">antiviral </span>
   <span class="font18">efflux </span>
   <span class="font18">inhibitors </span>
   <span class="font17">AET </span>
   <span class="font17">administration </span>
   <span class="font17">formulations </span>
   <span class="font17">order </span>
   <span class="font17">P-gp </span>
   <span class="font17">central </span>
   <span class="font17">AZT </span>
   <span class="font17">delivery </span>
   <span class="font17">nervous </span>
   <span class="font16">human </span>
   <span class="font16">transport </span>
   <span class="font16">HIV </span>
   <span class="font16">{border-style </span>
   <span class="font16">antiretroviral </span>
   <span class="font16">olfactory </span>
   <span class="font15">prodrug </span>
   <span class="font15">px;} </span>
   <span class="font15">transporters </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">CNS </span>
   <span class="font15">P-glycoprotein </span>
   <span class="font15">obtained </span>
   <span class="font15">cells </span>
   <span class="font15">virus </span>
   <span class="font14">chitosan </span>
   <span class="font14">activity </span>
   <span class="font14">appear </span>
   <span class="font14">endothelial </span>
   <span class="font14">systems </span>
   <span class="font14">formulation </span>
   <span class="font14">intranasal </span>
   <span class="font14">known </span>
   <span class="font14">substrates </span>
   <span class="font14">uptake </span>
   <span class="font14">zidovudine </span>
   <span class="font13">Pharm. </span>
   <span class="font13">[], </span>
   <span class="font13">expression </span>
   <span class="font13">induce </span>
   <span class="font13">macrophages </span>
   <span class="font13">Antiviral </span>
   <span class="font13">[,]. </span>
   <span class="font13">active </span>
   <span class="font13">based </span>
   <span class="font13">cell </span>
   <span class="font13">nanoparticles </span>
   <span class="font13">receptor </span>
   <span class="font13">saquinavir </span>
   <span class="font13">target </span>
   <span class="font13">Moreover, </span>
   <span class="font13">high </span>
   <span class="font13">new </span>
   <span class="font13">nose-to-brain </span>
   <span class="font13">particular, </span>
   <span class="font13">presence </span>
   <span class="font13">severe </span>
   <span class="font13">targeting </span>
   <span class="font12">BBB </span>
   <span class="font12">Nasal </span>
   <span class="font12">cavity </span>
   <span class="font12">distribution </span>
   <span class="font12">effects </span>
   <span class="font12">important </span>
   <span class="font12">increase </span>
   <span class="font12">mucoadhesive </span>
   <span class="font12">prodrugs </span>
   <span class="font12">resistance </span>
   <span class="font12">transporter </span>
   <span class="font12">type </span>
   <span class="font12">vitro </span>
   <span class="font12">HIV- </span>
   <span class="font12">Virus </span>
   <span class="font12">acid </span>
   <span class="font12">barrier </span>
   <span class="font12">blood-brain </span>
   <span class="font12">concentrations </span>
   <span class="font12">following </span>
   <span class="font12">higher </span>
   <span class="font12">microparticles </span>
   <span class="font12">microvessel </span>
   <span class="font12">pathway </span>
   <span class="font12">properties </span>
   <span class="font12">px; </span>
   <span class="font12">therapeutic </span>
   <span class="font12">using </span>
   <span class="font12">{font-family </span>
   <span class="font12">CSF </span>
   <span class="font12">[,,]. </span>
   <span class="font12">administered </span>
   <span class="font12">appears </span>
   <span class="font12">deposition </span>
   <span class="font12">efficacy </span>
   <span class="font12">enhance </span>
   <span class="font12">font-size </span>
   <span class="font12">gene </span>
   <span class="font12">increased </span>
   <span class="font12">induced </span>
   <span class="font12">inhibit </span>
   <span class="font12">innovative </span>
   <span class="font12">intravenous </span>
   <span class="font12">multidrug </span>
   <span class="font12">ritonavir, </span>
   <span class="font12">treatment </span>
   <span class="font12">unwanted </span>
   <span class="font11">Drugs </span>
   <span class="font11">Exp. </span>
   <span class="font11">MRP- </span>
   <span class="font11">Pharmacol. </span>
   <span class="font11">abacavir </span>
   <span class="font11">absorption </span>
   <span class="font11">administration, </span>
   <span class="font11">approach </span>
   <span class="font11">cassette </span>
   <span class="font11">conjugation </span>
   <span class="font11">currently </span>
   <span class="font11">devices </span>
   <span class="font11">direct </span>
   <span class="font11">double; </span>
   <span class="font11">encephalitis </span>
   <span class="font11">fluid </span>
   <span class="font11">infected </span>
   <span class="font11">inhibitor </span>
   <span class="font11">insulin </span>
   <span class="font11">mucosal </span>
   <span class="font11">promising </span>
   <span class="font11">proposed </span>
   <span class="font11">region </span>
   <span class="font11">release </span>
   <span class="font11">solid </span>
   <span class="font11">specific </span>
   <span class="font11">strategy </span>
   <span class="font11">studied </span>
   <span class="font11">substrate </span>
   <span class="font11">tight </span>
   <span class="font11">ABC </span>
   <span class="font11">ABCC </span>
   <span class="font11">ATP-binding </span>
   <span class="font11">Administration </span>
   <span class="font11">CCR </span>
   <span class="font11">CNS. </span>
   <span class="font11">Deliv../.. </span>
   <span class="font11">Formulations </span>
   <span class="font11">Innovative </span>
   <span class="font11">ability </span>
   <span class="font11">agents </span>
   <span class="font11">allowed </span>
   <span class="font11">anti-HIV </span>
   <span class="font11">binding </span>
   <span class="font11">blood </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">characterized </span>
   <span class="font11">compounds </span>
   <span class="font11">concentration </span>
   <span class="font11">demonstrated </span>
   <span class="font11">drugs, </span>
   <span class="font11">elude </span>
   <span class="font11">evidenced </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">indinavir </span>
   <span class="font11">induces </span>
   <span class="font11">interact </span>
   <span class="font11">levels </span>
   <span class="font11">model </span>
   <span class="font11">obtain </span>
   <span class="font11">pathways </span>
   <span class="font11">penetration </span>
   <span class="font11">permeate </span>
   <span class="font11">polymeric </span>
   <span class="font11">protease </span>
   <span class="font11">proteins </span>
   <span class="font11">rats </span>
   <span class="font11">receptors </span>
   <span class="font11">required </span>
   <span class="font11">reverse </span>
   <span class="font11">sanctuaries </span>
   <span class="font11">saquinavir, </span>
   <span class="font11">selective </span>
   <span class="font11">solid; </span>
   <span class="font11">strategies </span>
   <span class="font11">system. </span>
   <span class="font11">targeted </span>
   <span class="font11">time </span>
   <span class="font11">trigeminal </span>
   <span class="font11">use </span>
   <span class="font11">used </span>
   <span class="font11">values </span>
   <span class="font11">viral </span>
   <span class="font11">vivo </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">Drug </span>
   <span class="font11">Finally, </span>
   <span class="font11">MRP </span>
   <span class="font11">MRP, </span>
   <span class="font11">PVP </span>
   <span class="font11">Pharmacol../mol.. </span>
   <span class="font11">Recently, </span>
   <span class="font11">Taking </span>
   <span class="font11">Ther. </span>
   <span class="font11">Ther../jpet.. </span>
   <span class="font11">UDCA-AZT </span>
   <span class="font11">Venezuelan </span>
   <span class="font11">[,,,]. </span>
   <span class="font11">abacavir, </span>
   <span class="font11">act </span>
   <span class="font11">amounts </span>
   <span class="font11">amprenavir, </span>
   <span class="font11">bioavailability </span>
   <span class="font11">bold </span>
   <span class="font11">cancer </span>
   <span class="font11">cause </span>
   <span class="font11">cerebrospinal </span>
   <span class="font11">clinical </span>
   <span class="font11">constitute </span>
   <span class="font11">courier; </span>
   <span class="font11">data </span>
   <span class="font11">designed </span>
   <span class="font11">developed </span>
   <span class="font11">disease </span>
   <span class="font11">dolutegravir </span>
   <span class="font11">drugs. </span>
   <span class="font11">easily </span>
   <span class="font11">efficient </span>
   <span class="font11">em; </span>
   <span class="font11">entry </span>
   <span class="font11">example, </span>
   <span class="font11">family </span>
   <span class="font11">gel </span>
   <span class="font11">hydrophilic </span>
   <span class="font11">immune </span>
   <span class="font11">junctions </span>
   <span class="font11">ligands </span>
   <span class="font11">lipid </span>
   <span class="font11">loaded </span>
   <span class="font11">membranes </span>
   <span class="font11">mice </span>
   <span class="font11">molecular </span>
   <span class="font11">molecules </span>
   <span class="font11">necessary </span>
   <span class="font11">neurotropic </span>
   <span class="font11">nose </span>
   <span class="font11">optimize </span>
   <span class="font11">peripheral </span>
   <span class="font11">probenecid </span>
   <span class="font11">protein </span>
   <span class="font11">pt;} </span>
   <span class="font11">rate </span>
   <span class="font11">ratio </span>
   <span class="font11">residence </span>
   <span class="font11">resistance-associated </span>
   <span class="font11">result </span>
   <span class="font11">ribavirin </span>
   <span class="font11">showed </span>
   <span class="font11">shows </span>
   <span class="font11">simplex </span>
   <span class="font11">studies </span>
   <span class="font11">therapies </span>
   <span class="font11">tissue </span>
   <span class="font11">transcriptase </span>
   <span class="font11">ursodeoxycholic </span>
   <span class="font11">viruses </span>
   <span class="font11">well-known </span>
  </p>
 </body>
</html>
